Pet healthcare expenses can quickly become overwhelming, especially when an unexpected reaction or medical concern leads to emergency veterinary treatment. Recognising this concern among dog owners, NexGard has introduced a new customer support initiative called the Paw Promise, designed to provide financial reassurance to eligible pet parents using its flea and tick protection products.
The newly announced program aims to strengthen confidence in preventive pet care by offering reimbursement for certain veterinary expenses if an eligible dog experiences a qualifying issue after receiving NexGard as directed.
A New Layer of Confidence for Dog Owners
Preventing fleas and ticks is one of the most important aspects of canine healthcare, but many pet parents remain concerned about the potential costs associated with unexpected medical situations.
With the introduction of the Paw Promise, NexGard is offering an additional layer of protection—not for the pet itself, but for the owner’s financial peace of mind.
The initiative reflects a growing trend in the pet healthcare industry, where manufacturers are looking beyond products alone and expanding customer support through service-based programs.
How the Paw Promise Works
Under the program, eligible dog owners may receive reimbursement for specific veterinary expenses if their dog develops a qualifying issue after taking NexGard according to the approved label directions.
The company notes that reimbursement is subject to eligibility requirements and program terms, including veterinary evaluation and documentation. The program is intended to complement responsible veterinary care rather than replace professional medical treatment.
Pet owners are encouraged to consult their veterinarian promptly whenever they notice unusual symptoms or health concerns in their pets.
Encouraging Preventive Pet Care
Veterinarians consistently recommend year-round flea and tick prevention because parasites can transmit serious diseases and create long-term health complications for dogs.
NexGard, an oral chewable containing afoxolaner, is approved for the treatment and prevention of flea infestations and for controlling multiple tick species in dogs and puppies that meet the recommended age and weight requirements. It is administered once a month under veterinary guidance.
By pairing preventive treatment with customer reassurance, the Paw Promise initiative aims to encourage more pet parents to stay consistent with parasite protection.
Reflecting Changing Expectations in Pet Care
Today’s pet parents increasingly expect brands to provide support that extends beyond the product itself. Whether through educational resources, wellness programs, or financial assistance initiatives, companies are responding to a market where trust and long-term relationships are becoming just as important as product performance.
Industry experts say programs like Paw Promise demonstrate how pet healthcare companies are evolving to address not only animal wellbeing but also the practical concerns faced by pet owners.
Putting Pets and Prevention First
While no preventive treatment eliminates every possible health risk, early parasite protection remains one of the most effective ways to reduce flea- and tick-related illnesses.
The launch of the Paw Promise reinforces the importance of working closely with veterinarians, following recommended dosing schedules, and seeking prompt medical attention whenever concerns arise.
As the pet healthcare industry continues to innovate, initiatives that combine medical protection with customer support may become an increasingly important part of responsible pet ownership.
This article has been independently researched, written, and published by the Pets News Network (PNN) Editorial Team. Pets News Network (PNN) is India’s first dedicated OTT and digital news platform focused exclusively on the pet industry.
Published: July 2026
